Barhemsys
Amisulpride
Listed by Acacia Pharma Ltd
- Strength
- 2.5 mg/mL
- Form
- Injection, Solution
- Route
- Intravenous
- Class
- Dopamine-2 Receptor Antagonist
What it contains
- Amisulpride 2.5 mg/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Dopamine-2 Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 71390-125 |
| FDA application | NDA209510 |
| RxNorm concept | 2284232 |
| Package sizes listed | 2 |
| Marketed since | February 2020 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.